Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 129.00
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
TPEX:6712 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11,300 | 14,366 | 14,158 | 14,338 | 15,025 | 13,013 | Upgrade
|
| Market Cap Growth | -18.51% | 1.47% | -1.25% | -4.57% | 15.46% | 32.03% | Upgrade
|
| Enterprise Value | 10,903 | 14,053 | 13,525 | 13,324 | 13,889 | 11,764 | Upgrade
|
| Last Close Price | 129.00 | 160.00 | 151.05 | 148.42 | 150.75 | 127.56 | Upgrade
|
| PE Ratio | 26.43 | 33.45 | 38.55 | 26.58 | 74.86 | 35.21 | Upgrade
|
| Forward PE | 20.98 | 42.17 | 42.17 | 41.07 | 44.55 | - | Upgrade
|
| PS Ratio | 11.11 | 14.12 | 15.16 | 18.91 | 23.94 | 29.65 | Upgrade
|
| PB Ratio | 7.40 | 9.41 | 7.89 | 7.78 | 8.38 | 6.86 | Upgrade
|
| P/TBV Ratio | 7.47 | 9.49 | 7.94 | 7.83 | 8.44 | 6.90 | Upgrade
|
| P/FCF Ratio | 21.12 | 26.85 | 32.51 | 34.47 | 47.55 | 97.33 | Upgrade
|
| P/OCF Ratio | 21.07 | 26.79 | 32.15 | 34.00 | 47.07 | 95.90 | Upgrade
|
| EV/Sales Ratio | 10.72 | 13.81 | 14.48 | 17.57 | 22.13 | 26.81 | Upgrade
|
| EV/EBITDA Ratio | 24.09 | 31.17 | 30.72 | 37.25 | 45.20 | 83.16 | Upgrade
|
| EV/EBIT Ratio | 25.37 | 32.01 | 32.11 | 39.45 | 48.94 | 101.24 | Upgrade
|
| EV/FCF Ratio | 20.38 | 26.26 | 31.06 | 32.04 | 43.95 | 87.99 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.08 | 0.01 | 0.02 | 0.06 | 0.23 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.07 | 0.01 | 0.01 | 0.06 | 0.26 | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.26 | -0.52 | -0.72 | -0.70 | -0.69 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.88 | -0.88 | -2.12 | -3.72 | -4.07 | -9.26 | Upgrade
|
| Net Debt / FCF Ratio | -0.74 | -0.74 | -2.15 | -3.20 | -3.96 | -9.79 | Upgrade
|
| Asset Turnover | 0.49 | 0.49 | 0.44 | 0.38 | 0.31 | 0.31 | Upgrade
|
| Inventory Turnover | 3.80 | 3.80 | 3.67 | 3.48 | 2.94 | 4.19 | Upgrade
|
| Quick Ratio | 1.59 | 1.59 | 3.46 | 6.20 | 8.28 | 14.58 | Upgrade
|
| Current Ratio | 1.78 | 1.78 | 3.72 | 6.57 | 8.89 | 15.20 | Upgrade
|
| Return on Equity (ROE) | 25.86% | 25.86% | 20.19% | 29.68% | 10.88% | 27.60% | Upgrade
|
| Return on Assets (ROA) | 13.25% | 13.25% | 12.50% | 10.42% | 8.88% | 5.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 32.59% | 36.16% | 48.91% | 55.47% | 38.21% | 21.70% | Upgrade
|
| Return on Capital Employed (ROCE) | 27.80% | 27.80% | 23.30% | 18.30% | 15.70% | 6.00% | Upgrade
|
| Earnings Yield | 3.80% | 2.99% | 2.59% | 3.76% | 1.34% | 2.84% | Upgrade
|
| FCF Yield | 4.74% | 3.72% | 3.08% | 2.90% | 2.10% | 1.03% | Upgrade
|
| Dividend Yield | 2.68% | 2.19% | 3.01% | 3.34% | 1.00% | 2.68% | Upgrade
|
| Payout Ratio | 94.96% | 94.96% | 119.82% | 25.27% | 154.19% | - | Upgrade
|
| Buyback Yield / Dilution | 0.92% | 0.92% | 1.68% | 1.01% | -0.15% | -11.01% | Upgrade
|
| Total Shareholder Return | 3.56% | 3.10% | 4.68% | 4.35% | 0.85% | -8.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.